메뉴 건너뛰기




Volumn 116, Issue 19, 2007, Pages 2096-2098

The transforming growth factor-β/Smad3 pathway: Coming of age as a key participant in cardiac remodeling

Author keywords

Editorials; Inflammation; Myocardial infarction; Remodeling; Smad3 protein; Transforming growth factor

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 35948973209     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.735381     Document Type: Editorial
Times cited : (11)

References (31)
  • 1
    • 0026354053 scopus 로고
    • Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and management
    • Braunwald E, Pfeffer MA. Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am J Cardiol 1991;68:1D-6D.
    • (1991) Am J Cardiol , vol.68
    • Braunwald, E.1    Pfeffer, M.A.2
  • 2
    • 0033939770 scopus 로고    scopus 로고
    • Postinfarction left ventricular remodeling: A pathophysiological and therapeutic review
    • Yousef ZR, Redwood SR, Marber MS. Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review. Cardiovasc Drugs Ther. 2000;14:243-252.
    • (2000) Cardiovasc Drugs Ther , vol.14 , pp. 243-252
    • Yousef, Z.R.1    Redwood, S.R.2    Marber, M.S.3
  • 4
    • 0026695294 scopus 로고
    • The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
    • Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
    • (1992) J Am Coll Cardiol , vol.20 , pp. 248-254
    • Packer, M.1
  • 5
    • 0347987900 scopus 로고    scopus 로고
    • Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways
    • Fu YC, Chi CS, Yin SC, Hwang B, Chiu YT, Hsu SL. Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways. Cardiovasc Res. 2004;61:143-151.
    • (2004) Cardiovasc Res , vol.61 , pp. 143-151
    • Fu, Y.C.1    Chi, C.S.2    Yin, S.C.3    Hwang, B.4    Chiu, Y.T.5    Hsu, S.L.6
  • 6
    • 14944362972 scopus 로고    scopus 로고
    • Healing after myocardial infarction
    • Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res. 2005;66:22-32.
    • (2005) Cardiovasc Res , vol.66 , pp. 22-32
    • Ertl, G.1    Frantz, S.2
  • 9
    • 0023219810 scopus 로고
    • Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction
    • White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
    • (1987) Circulation , vol.76 , pp. 44-51
    • White, H.D.1    Norris, R.M.2    Brown, M.A.3    Brandt, P.W.4    Whitlock, R.M.5    Wild, C.J.6
  • 10
    • 0034975055 scopus 로고    scopus 로고
    • Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: Their inter-relation and prognostic impact
    • Gaudron P, Kugler I, Hu K, Bauer W, Eilles C, Ertl G. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol. 2001;38:33-40.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 33-40
    • Gaudron, P.1    Kugler, I.2    Hu, K.3    Bauer, W.4    Eilles, C.5    Ertl, G.6
  • 11
    • 33746829275 scopus 로고    scopus 로고
    • Transforming growth factor-betas and vascular disorders
    • Bobik A. Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol. 2006;26:1712-1720.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 1712-1720
    • Bobik, A.1
  • 12
    • 35048875855 scopus 로고    scopus 로고
    • TGF-beta signaling: A tale of two responses
    • Rahimi RA, Leof EB. TGF-beta signaling: a tale of two responses. J Cell Biochem. 2007;102:593-608.
    • (2007) J Cell Biochem , vol.102 , pp. 593-608
    • Rahimi, R.A.1    Leof, E.B.2
  • 13
    • 0028932732 scopus 로고
    • ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
    • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group
    • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
    • (1995) Lancet , vol.345 , pp. 669-685
  • 14
    • 1642494797 scopus 로고    scopus 로고
    • Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: The CAPRICORN Echo Substudy
    • Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation. 2004;109:201-206.
    • (2004) Circulation , vol.109 , pp. 201-206
    • Doughty, R.N.1    Whalley, G.A.2    Walsh, H.A.3    Gamble, G.D.4    Lopez-Sendon, J.5    Sharpe, N.6
  • 15
    • 0035810547 scopus 로고    scopus 로고
    • Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
    • Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385-1390.
    • (2001) Lancet , vol.357 , pp. 1385-1390
    • Dargie, H.J.1
  • 16
    • 0027499036 scopus 로고
    • Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors
    • Borghi C, Boschi S, Ambrosioni E, Melandri G, Branzi A, Magnani B. Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol. 1993;33:40-45.
    • (1993) J Clin Pharmacol , vol.33 , pp. 40-45
    • Borghi, C.1    Boschi, S.2    Ambrosioni, E.3    Melandri, G.4    Branzi, A.5    Magnani, B.6
  • 17
    • 0019508224 scopus 로고
    • Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure
    • Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981;63:645-651.
    • (1981) Circulation , vol.63 , pp. 645-651
    • Dzau, V.J.1    Colucci, W.S.2    Hollenberg, N.K.3    Williams, G.H.4
  • 18
    • 23944446113 scopus 로고    scopus 로고
    • Early time to benefit with intensive statin treatment: Could it be the pleiotropic effects?
    • Ray KK, Cannon CP. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? Am J Cardiol 2005;96:54F-60F.
    • (2005) Am J Cardiol , vol.96
    • Ray, K.K.1    Cannon, C.P.2
  • 19
    • 26844447541 scopus 로고    scopus 로고
    • 22 Investigators. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: Results from the PROVE IT-TIMI 22 trial
    • Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E; PROVE IT-TIMI 22 Investigators. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005;46:1405-1410.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1405-1410
    • Ray, K.K.1    Cannon, C.P.2    McCabe, C.H.3    Cairns, R.4    Tonkin, A.M.5    Sacks, F.M.6    Jackson, G.7    Braunwald, E.8
  • 20
    • 85047679265 scopus 로고
    • Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease
    • Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994;28:1301-1311.
    • (1994) Cardiovasc Res , vol.28 , pp. 1301-1311
    • Entman, M.L.1    Smith, C.W.2
  • 22
    • 0028231065 scopus 로고
    • Adhesion molecules and inflammatory injury
    • Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. Faseb J. 1994;8:504-512.
    • (1994) Faseb J , vol.8 , pp. 504-512
    • Albelda, S.M.1    Smith, C.W.2    Ward, P.A.3
  • 23
    • 1842329163 scopus 로고    scopus 로고
    • Mechanisms of neutrophil-induced parenchymal cell injury
    • Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol. 1997;61:647-653.
    • (1997) J Leukoc Biol , vol.61 , pp. 647-653
    • Jaeschke, H.1    Smith, C.W.2
  • 24
    • 0034683031 scopus 로고    scopus 로고
    • Status of myocardial antioxidants in ischemia-reperfusion injury
    • Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000;47:446-456.
    • (2000) Cardiovasc Res , vol.47 , pp. 446-456
    • Dhalla, N.S.1    Elmoselhi, A.B.2    Hata, T.3    Makino, N.4
  • 26
    • 0042917638 scopus 로고    scopus 로고
    • COMMA Investigators. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial
    • Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochman JS, Filloon TG, Rollins S, Todaro TG, Nicolau JC, Ruzyllo W, Armstrong PW; COMMA Investigators. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation. 2003;108:1184-1190.
    • (2003) Circulation , vol.108 , pp. 1184-1190
    • Granger, C.B.1    Mahaffey, K.W.2    Weaver, W.D.3    Theroux, P.4    Hochman, J.S.5    Filloon, T.G.6    Rollins, S.7    Todaro, T.G.8    Nicolau, J.C.9    Ruzyllo, W.10    Armstrong, P.W.11
  • 27
    • 0041732120 scopus 로고    scopus 로고
    • COMPLY Investigators. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial
    • Mahaffey KW, Granger CB, Nicolau JC, Ruzyllo W, Weaver WD, Theroux P, Hochman JS, Filloon TG, Mojcik CF, Todaro TG, Armstrong PW; COMPLY Investigators. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation. 2003;108:1176-1783.
    • (2003) Circulation , vol.108 , pp. 1176-1783
    • Mahaffey, K.W.1    Granger, C.B.2    Nicolau, J.C.3    Ruzyllo, W.4    Weaver, W.D.5    Theroux, P.6    Hochman, J.S.7    Filloon, T.G.8    Mojcik, C.F.9    Todaro, T.G.10    Armstrong, P.W.11
  • 28
    • 0035808003 scopus 로고    scopus 로고
    • Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST, Gibbons RJ, Borzak S, Sobel BE, Gourlay SG, Rundle AC, Gibson CM, Barron HV; Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study Group. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 2001;104:2778-2783.
    • Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST, Gibbons RJ, Borzak S, Sobel BE, Gourlay SG, Rundle AC, Gibson CM, Barron HV; Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study Group. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 2001;104:2778-2783.
  • 29
    • 0037010009 scopus 로고    scopus 로고
    • The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: The results of the HALT-MI study
    • Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol. 2002;40:1199-1204.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1199-1204
    • Faxon, D.P.1    Gibbons, R.J.2    Chronos, N.A.3    Gurbel, P.A.4    Sheehan, F.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.